Main Subject
#1 in Business Subscribe Email Print

You are here: Home > Business > Business > Making The Business Case For Corporate Performance Management

Tags

  • implementing
  • developing combination
  • recent years
  • budgeting system

  • Links

  • Reiki Practitioners: Choose Your Reiki Practitioner Wisely
  • Best Friend Poems
  • Rules for Living a Kosher Lifestyle
  • Main Subject - Making The Business Case For Corporate Performance Management

    Anyone involved in high value capital sales, such as enterprise software, will know life can be a roller coaster. One day everyone is on a high as a major deal is secured. Another day everyone is distraught when after many months of work, it comes to nothing. Losing out to another vendor is an accepted part of th
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    e game.

    More annoying is the situation where you have been told you are the preferred supplier - and after all the euphoria, nothing happens. Typically any enquiry reveals that the proposal is "still with the board", or "has been put back until next quarter". The reality is that it’s a dodo; kicked o
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    t because the project team failed to build a compelling business case for the investment and the resources have been allocated elsewhere. The vendor team only have themselves to blame. They should have identified that funding for the project had not been authorized and helped the project team develop the business
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    case.

    In the 90’s organizations invested heavily in enterprise resource planning (ERP), and customer relationship management (CRM) systems. In the current decade, the focus of much IT spending is predicted to switch to corporate performance management (CPM) suites; integrating previously stand-alone a
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    plication areas such as budgeting, scorecards and costing to provide better insight into current and future financial performance.

    But a lot has happened in the last decade. Many organizations invested heavily in ERP and are still not convinced of the benefits. Global IT analysts, the Meta Group, rece
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    tly did a study looking at the total cost of ownership (TCO) of ERP over the first two years. Among the 63 companies surveyed-including small, medium and large companies in a range of industries - the average TCO was $15 million. But there was a payback. After 31 months, Meta found median annual savings of $1.6 m
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    illion. On that basis, it would take nearly a decade to reach break even!

    Such experiences, together with the downturn in most western economies, have depressed IT spending in recent years and boards are right to be skeptical about further spending. This puts the onus on project teams seeking to secure
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    funding for Corporate Performance Management initiatives to develop a credible and compelling business case with a break even that comes sooner rather than later. Step one is to identify the total cost of ownership year by year over a suitable period of time. Beside including the obvious cost of software, hardw
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    re, professional services and training, it is important to include the cost of internal staff.

    Step two is to quantify the benefits. For instance, most of the quantifiable benefit of implementing a new budgeting application is likely to come from a reduction in resources in the finance function. If bu
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    geting was previously done using spreadsheets, it is likely that there was an inordinate amount of work involved in preparing schedules, chasing submissions and re-keying data. Implementing a new system will remove much of this work and these savings should be costed and included in the business case. The cost sa
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ing of one part qualified management accountant over a five-year period will get you well on the way to break even.

    At the same time, implementing a new budgeting system is likely to reduce the amount of time it takes line managers to prepare and review their budgets. The opportunity cost of saving th
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ree working days a year for two hundred cost center managers with an average benefits package of $75, 000 is sizeable. I calculate this to be an annual saving of $210,000 - over $1,050,000 over a five-year period. Once the annual costs and benefits have been identified, they can be discounted at an appropriate co
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    t of capital to give a net present value (NPV) and break even.

    Your vendor can put you in contact with other organizations that have undertaken similar implementations and they will be able to provide you with some idea of the savings that can be made. Alternatively, if your organization subscribes to
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    an analyst group, they will have a specialist in Corporate Performance Management who will be able to provide guidelines on likely benefits. The results can be impressive with break even being reached in a matter of months rather than years, even when some of the more questionable cost savings are excluded.
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    But be transparent with your assessments, presenting a range of scenarios showing a good outcome, a poor outcome and the most likely result. It will help your credibility, especially if your most pessimistic scenario is still positive. Having clearly demonstrated a cost benefit, all the other less quantifiable
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    easons for implementing a new budgeting application are likely to win the day and help secure the funding. For instance, implementing a budgeting system that allows the organization to re-forecast more frequently is likely to result in more accurate forecasts. It is also likely to enable the organization to becom
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    e much more agile with managers able to rapidly realign resources with changing patterns of trading. Being able to demonstrate to the board exactly how implementing monthly rolling re-forecasts will enable line managers to manage their capacity better may be more compelling than simply showing a positive NPV. On
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    e an implementation is deployed, the costs and benefits should be fully reviewed to check that the projected savings are achieved. Providing this feedback to the board and senior managers will reassure them that they made the right investment decision and make it easier to secure funding next time around. Again d
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    n’t forget to include a review of other benefits such as how the organization can now re-forecast every month, chasing down instances of how this has directly benefited individual managers. In my experience once cost savings have been identified, the other benefits suddenly become much more important.

    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    About Richard Barrett: "Richard Barrett oversees ALG Software's marketing worldwide. As an expert in corporate performance management, Richard has had a diverse career spanning more than two decades across multiple industries, including financial services.


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.mainsubjects.org.ua/article/972/mainsubjects-Making-The-Business-Case-For-Corporate-Performance-Management.html">Making The Business Case For Corporate Performance Management</a>

    BB link (for phorums):
    [url=http://www.mainsubjects.org.ua/article/972/mainsubjects-Making-The-Business-Case-For-Corporate-Performance-Management.html]Making The Business Case For Corporate Performance Management[/url]

    Related Articles:

    What Makes An Outstanding Salesperson

    Opening A Dollar Store - Does Location Really Make a Difference?

    Five Simple Steps To Double Your Income

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com